P. Zanovello

Museum of Thermalism: A development project and an ancient shared heritage between Italy and Egypt
20220 citationsauthor #1
Responsiveness to Hedgehog Pathway Inhibitors in T-Cell Acute Lymphoblastic Leukemia Cells Is Highly Dependent on 5′AMP-Activated Kinase Inactivation
20211 citationsauthor #5
Water Supply in Pre-Desert Areas along the Limes
20200 citationsauthor #1
miR-22-3p Negatively Affects Tumor Progression in T-Cell Acute Lymphoblastic Leukemia
202017 citationsauthor #8
Cross-talk between GLI transcription factors and FOXC1 promotes T-cell acute lymphoblastic leukemia dissemination
202011 citationsauthor #12
Crosstalk between Hedgehog pathway and the glucocorticoid receptor pathway as a basis for combination therapy in T-cell acute lymphoblastic leukemia
202011 citationsauthor #6
A Dig through Archives and Depots
20192 citationsauthor #5
Silencing of miR-182 is associated with modulation of tumorigenesis through apoptosis induction in an experimental model of colorectal cancer
201923 citationsauthor #12
Results and Future Prospects
20193 citationsauthor #2
Clonal heterogeneity of melanoma in a paradigmatic case study: future prospects for circulating melanoma cells
20194 citationsauthor #8
A coordinate deregulation of microRNAs expressed in mucosa adjacent to tumor predicts relapse after resection in localized colon cancer
201819 citationsauthor #9
Advanced Visual Interfaces to Represent Cultural and Historical Facts and Associations in the CrossCult EU project
20183 citationsauthor #6
Current and past research between Tebtynis and Padua:
20182 citationsauthor #14
Ptolemaic Glass Inlays between Tradition and Innovation: a Closer Look at the Tebtynis Workshop
20180 citationsauthor #4
Chemotactic Cues for NOTCH1-Dependent Leukemia
201817 citationsauthor #4
Circulating miRNA‐375 as a potential novel biomarker for active Kaposi’s sarcoma in AIDS patients
201810 citationsauthor #8
Discovering Coptic Churches at Tebtunis
20170 citationsauthor #2
Korus — A drone project for visual and IR imaging
20175 citationsauthor #10
Looking at water shortage from a Roman point of view: a survey of Literary sources and epigraphical attestations from Italian regiones
20170 citationsauthor #3
Identification of a HLA-A*0201-restricted immunogenic epitope from the universal tumor antigen DEPDC1
201714 citationsauthor #7
Cytokines for the induction of antitumor effectors: The paradigm of Cytokine-Induced Killer (CIK) cells.
201751 citationsauthor #3
A BARF1-specific mAb as a new immunotherapeutic tool for the management of EBV-related tumors
201713 citationsauthor #9
WT1 loss attenuates the TP53-induced DNA damage response in T-cell acute lymphoblastic leukemia
201720 citationsauthor #10
Predictors of immune reconstitution inflammatory syndrome associated with Kaposi’s sarcoma: a case report
201611 citationsauthor #7
Reconstruction of gene regulatory modules from RNA silencing of IFN-α modulators: experimental set-up and inference method
20163 citationsauthor #5
Spatial organization of a proto-historic settlement in northern Italy: combining 8 bands satellite images, ‘Structure from Motion’-derived Digital Elevation Models and fieldwork data
20160 citationsauthor #10
T Cell Cancer Therapy Requires CD40-CD40L Activation of Tumor Necrosis Factor and Inducible Nitric-Oxide-Synthase-Producing Dendritic Cells.
201654 citationsauthor #10
A circulating miRNA assay as a first-line test for prostate cancer screening
201657 citationsauthor #7
Loss of zfp36 expression in colorectal cancer correlates to wnt/ β-catenin activity and enhances epithelial-to-mesenchymal transition through upregulation of zeb1, sox9 and macc1
201650 citationsauthor #9
Horus Project: aerospace technologies for the archaeological research
20160 citationsauthor #12
A site-selective hyaluronan-interferonα2a conjugate for the treatment of ovarian cancer.
201623 citationsauthor #10
Retargeting cytokine-induced killer cell activity by CD16 engagement with clinical-grade antibodies
201634 citationsauthor #3
Egyptian glass inlays from Tebtynis workshop: first steps of the research
20160 citationsauthor #4
Reconstruction of gene regulatory modules from RNA silencing of IFN-α modulators: experimental set-up and inference method
20160 citationsauthor #5
T Cell Cancer Therapy Requires CD40-CD40L Activation of Tumor Necrosis Factor and Inducible Nitric-Oxide-Synthase-Producing Dendritic Cells.
2016161 citationsauthor #10
Town planning at Tebtynis
20150 citationsauthor #1
Identification of a HLA-A*0201-restricted immunogenic epitope from the universal tumor antigen DEPDC1
20151 citationsauthor #4
The project: Archaeometric study of Egyptian vitreous materials form Tebtynis
20150 citationsauthor #4
Archaeology and virtual acoustics. A pan flute from ancient Egypt
201520 citationsauthor #14
Drug conjugation to hyaluronan widens therapeutic indications for ovarian cancer
201519 citationsauthor #8
Autologous cellular vaccine overcomes cancer immunoediting in a mouse model of myeloma
20157 citationsauthor #13
Location of the Deposit of Papyri from the Temple Library at Tebtunis Identified
20151 citationsauthor #1
Circulating miR-182 is a biomarker of colorectal adenocarcinoma progression
201455 citationsauthor #14
targeting of NOTCH3 by miR-150 Modulation of microRNA expression in human T-cell development:
20140 citationsauthor #2
PSMA-Specific CAR-Engineered T Cells Eradicate Disseminated Prostate Cancer in Preclinical Models
201476 citationsauthor #10
Human miRNome profiling in colorectal cancer and liver metastasis development
201411 citationsauthor #14
Peritoneal Tumor Carcinomatosis: Pharmacological Targeting with Hyaluronan-Based Bioconjugates Overcomes Therapeutic Indications of Current Drugs
201411 citationsauthor #7
An integrative framework identifies alternative splicing events in colorectal cancer development
201443 citationsauthor #7
Functional Avidity–Driven Activation-Induced Cell Death Shapes CTL Immunodominance
20146 citationsauthor #12
Proceedings of ICI Milan 2013
20140 citationsauthor #7
Characterization of Clinical and Molecular Features Related to the Downregulated Expression of μ-Protocadherin in Colorectal Cancer.
20143 citationsauthor #9
Immunodominanceed Cell Death Shapes CTL Driven - Functional Avidity
20140 citationsauthor #2
Small Noncoding RNAs in Cells Transformed by Human T-Cell Leukemia Virus Type 1: a Role for a tRNA Fragment as a Primer for Reverse Transcriptase
2014127 citationsauthor #8
Survivin Expression and Prognostic Significance in Pediatric Malignant Peripheral Nerve Sheath Tumors (MPNST)
201319 citationsauthor #12
Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis
20132 citationsauthor #14
Potential applications of circulating melanoma cells (CMCs) expressing γ-H2AX.
20130 citationsauthor #9
Paclitaxel-hyaluronan hydrosoluble bioconjugate: mechanism of action in human bladder cancer cell lines.
201333 citationsauthor #7
Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis
2013164 citationsauthor #14
Trachyte from the Roman aqueducts of Padua and Este (north-east Italy): a provenance study based on petrography, chemistry and magnetic susceptibility
201316 citationsauthor #6
miR-142-3p prevents macrophage differentiation during cancer-induced myelopoiesis.
2013136 citationsauthor #13
Dissecting the molecular regulatory networks in human myeloid-derived suppressor cells
20120 citationsauthor #6
The microRNA regulatory network in normal- and HTLV-1-transformed T cells.
20126 citationsauthor #2
Deregulated microRNA expression in childhood T-cell lymphoblastic lymphoma
20120 citationsauthor #4
Upregulation of myeloid derived suppressor cells (MDSCs) in chronic obstructive pulmonary disease and its relationship with disease severity
20120 citationsauthor #10
MicroRNA expression in HTLV-1 infection and pathogenesis
20110 citationsauthor #11
Differential down-modulation of HLA class I and II molecule expression on human tumor cell lines upon in vivo transfer
20116 citationsauthor #4
telomerase-specific T lymphocytes Autoimmune B-cell lymphopenia after successful adoptive therapy with
20110 citationsauthor #1
Immunotherapy for EBV-associated malignancies
201132 citationsauthor #4
A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells.
2011335 citationsauthor #9
Glycolytic phenotype and AMP kinase modify the pathologic response of tumor xenografts to VEGF neutralization.
201172 citationsauthor #17
Modulation of microRNA expression in human T-cell development: targeting of NOTCH3 by miR-150.
2011228 citationsauthor #19
Myeloid derived suppressor cells in the crosstalk between COPD and lung cancer
20111 citationsauthor #10
Immune response to Moloney-murine leukemia virus-induced antigens in bone marrow.
20113 citationsauthor #5
Impact of γ-chain cytokines on EBV-specific T cell cultures
20104 citationsauthor #4
IFN-gamma-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer.
2010121 citationsauthor #10
In vivo administration of artificial Antigen Presenting Cells licenses low avidity T cells for treatment of cancer (131.13)
20100 citationsauthor #7
Myeloid-derived suppressor cell heterogeneity and subset definition.
2010676 citationsauthor #5
Tumor-induced tolerance and immune suppression depend on the C/EBPbeta transcription factor.
2010894 citationsauthor #13
Virus-Specific Cytotoxic CD4+ T Cells for the Treatment of EBV-Related Tumors
201053 citationsauthor #8
Role of microRNAs in HTLV-1 infection and transformation.
201042 citationsauthor #3
Autoimmune B-cell lymphopenia after successful adoptive therapy with telomerase-specific T lymphocytes.
201032 citationsauthor #12
IL4Rα+ Myeloid-Derived Suppressor Cell Expansion in Cancer Patients1
2009302 citationsauthor #11
Differential expression of constitutive and inducible proteasome subunits in human monocyte‐derived DC differentiated in the presence of IFN‐α or IL‐4
200930 citationsauthor #11
The Relationship between Immune System and Cancer: Immunosurveillance and Immunosuppression
20090 citationsauthor #1
Reprogramming T lymphocytes for melanoma adoptive immunotherapy by T-cell receptor gene transfer with lentiviral vectors.
200960 citationsauthor #10
GM-CSF and IL-6 induce tolerogenic myeloid-derived suppressor cells through C/EBP beta and allow long term islet allograft survival
20090 citationsauthor #14
Biodistribution imaging of a paclitaxel-hyaluronan bioconjugate.
200927 citationsauthor #9
In vivo administration of artificial antigen-presenting cells activates low-avidity T cells for treatment of cancer.
200966 citationsauthor #6
Preventive vaccination with telomerase controls tumor growth in genetically engineered and carcinogen-induced mouse models of cancer.
200846 citationsauthor #10
Tumor‐induced tolerance and immune suppression by myeloid derived suppressor cells
2008627 citationsauthor #4
A paclitaxel-hyaluronan bioconjugate exerts a high in vivo therapeutic activity against ovarian cancer
20080 citationsauthor #6
285 CLINICAL RADIOLOGICAL AND IMMUNOGENETIC ASPECTS OF EROSIVE OSTEOARTHRITIS (EOA) OF THE HAND IN A GROUP OF PATIENTS FOLLOWED FOR 2 YEARS FROM A SINGLE CENTER
20080 citationsauthor #8
Adoptive cell therapy against EBV-related malignancies: a survey of clinical results
200821 citationsauthor #4
IFN-gamma- Mediated Upmodulation of MHC Class I Expression Associated to a B7-1-Expressing Tumor Cell Vaccine Activates Tumor-Specific Immune Response in a Mouse Model of Prostate Cancer.
20080 citationsauthor #10
Myeloid-derived suppressor cell role in tumor-related inflammation.
2008123 citationsauthor #5
A Paclitaxel-Hyaluronan Bioconjugate Targeting Ovarian Cancer Affords a Potent In vivo Therapeutic Activity
200893 citationsauthor #10
Role of arginine metabolism in immunity and immunopathology.
2008185 citationsauthor #9
Adoptive cell therapy against EBV-related malignancies: a survey of clinical results.
200829 citationsauthor #4
T-cell receptor gene transfer by lentiviral vectors in adoptive cell therapy
200717 citationsauthor #2
aAPC immunization activates low affinity T cells for treatment of tumors (B147)
20070 citationsauthor #5

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT